[PDF][PDF] Idiopathic inflammatory myopathies: one year in review 2021

C Cardelli, G Zanframundo, L Cometi… - Clin Exp …, 2022 - researchgate.net
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of rare and complex
connective tissue diseases, mainly characterised by inflammatory involvement of skeletal …

Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis

S Nayebirad, A Mohamadi… - BMJ Open …, 2023 - bmjopenrespres.bmj.com
Objectives Interstitial lung disease (ILD) is an important manifestation of autoimmune
diseases that can lead to morbidity and mortality. Although several autoantibodies have …

Predictive features and clinical presentation of interstitial lung disease in inflammatory myositis

T Vojinovic, I Cavazzana, P Ceruti, M Fredi… - Clinical Reviews in …, 2021 - Springer
Interstitial lung disease (ILD) represents one of the most severe extra-muscular features of
idiopathic inflammatory myositis (IIM). We aimed to identify any clinical and serological …

The prognostic role of C-reactive protein to albumin ratio and anti-MDA5 antibody-positive in idiopathic inflammatory myopathy: a retrospective study

P Zhou, Q Shen, S Zhou, X Ouyang, T Guo, M Song… - Scientific reports, 2023 - nature.com
This cohort study aimed to identify the characteristics and risk factors of adult idiopathic
inflammatory myopathy-associated interstitial lung disease (IIM-ILD) and further explore the …

Cytokeratin 19 fragment is associated with severity and poor prognosis of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis

X Gui, M Ma, J Ding, SY Shi, X Xin, X Qiu… - …, 2021 - academic.oup.com
Objectives In the present study, we aimed to assess the clinical significance of cytokeratin 19
fragment (CYFRA21-1) in patients with anti-melanoma differentiation-associated gene 5 …

Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a …

Q Ji, W Pan, D Zhang, Y Hou, Z Wang - Frontiers in Immunology, 2023 - frontiersin.org
Background Clinically amyopathic dermatomyositis (CADM) is a distinct subtype of
dermatomyositis (DM) characterized by typical DM cutaneous findings but with minimal or no …

Clinical characteristics and management of patients with clinical amyopathic dermatomyositis: a retrospective study of 64 patients at a tertiary dermatology department

K Tang, H Zhang, H Jin - Frontiers in Medicine, 2021 - frontiersin.org
Background: Clinical amyopathic dermatomyositis (CADM) represents a subtype of 5–20%
of patients with dermatomyositis (DM), which can be categorized into amyopathic …

Clinical and HRCT features of amyopathic dermatomyositis associated with interstitial lung disease: A retrospective study of 128 patients with connective tissue …

T Wu, H Zhou, S Xu, Z Deng, Y Zhang… - The American journal of the …, 2023 - Elsevier
Background This study retrospectively analyzed the laboratory data and chest images of
patients with amyopathic dermatomyositis associated with interstitial lung disease (ADM …

Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease

H Cao, J Huang, J Chang, Y Zhu, J Liang… - Journal of …, 2023 - degruyter.com
The idiopathic inflammatory myopathies (IIMs) are a group of connective tissue diseases that
afect multiple organ systems, including the lungs. Interstitial lung disease (ILD) is the most …

The efficacy and safety of rituximab in patients with idiopathic inflammatory myopathy-associated interstitial lung disease: case series

Y Jang, HY Yoon, HS Kim - Journal of Clinical Medicine, 2023 - mdpi.com
Idiopathic inflammatory myopathy (IIM)-associated interstitial lung disease (ILD) is often
rapidly progressive with a poor prognosis; however, no standard therapeutic regimen has …